Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125362852 | 12536285 | 2 | F | 20150108 | 20160715 | 20160707 | 20160726 | EXP | JP-ELI_LILLY_AND_COMPANY-JP201607001149 | ELI LILLY AND CO | 65.00 | YR | M | Y | 0.00000 | 20160725 | CN | DE | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125362852 | 12536285 | 1 | PS | ERBITUX | CETUXIMAB | 1 | Intravenous (not otherwise specified) | 400 MG, WEEKLY (1/W) | U | U | 125084 | 400 | MG | INJECTION | /wk | ||||
| 125362852 | 12536285 | 2 | SS | ERBITUX | CETUXIMAB | 1 | Intravenous (not otherwise specified) | 250 MG, WEEKLY (1/W) | U | U | 125084 | 250 | MG | INJECTION | /wk | ||||
| 125362852 | 12536285 | 3 | SS | ERBITUX | CETUXIMAB | 1 | Unknown | UNK, UNKNOWN | U | U | 125084 | INJECTION | |||||||
| 125362852 | 12536285 | 4 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | 80 MG, EVERY 3 WEEKS | U | U | 0 | 80 | MG | ||||||
| 125362852 | 12536285 | 5 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Unknown | UNK UNK, UNKNOWN | U | U | 0 | ||||||||
| 125362852 | 12536285 | 6 | C | 5 FU | FLUOROURACIL | 1 | Unknown | 800 MG, EVERY 3 WEEKS | U | 0 | 800 | MG | |||||||
| 125362852 | 12536285 | 7 | C | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | UNK, UNKNOWN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125362852 | 12536285 | 1 | Hypopharyngeal cancer |
| 125362852 | 12536285 | 4 | Hypopharyngeal cancer |
| 125362852 | 12536285 | 5 | Product used for unknown indication |
| 125362852 | 12536285 | 6 | Hypopharyngeal cancer |
| 125362852 | 12536285 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125362852 | 12536285 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125362852 | 12536285 | Hypomagnesaemia | |
| 125362852 | 12536285 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125362852 | 12536285 | 1 | 20140411 | 0 | ||
| 125362852 | 12536285 | 2 | 20160413 | 0 | ||
| 125362852 | 12536285 | 3 | 20160622 | 0 | ||
| 125362852 | 12536285 | 4 | 20140411 | 20160426 | 0 | |
| 125362852 | 12536285 | 6 | 20140411 | 0 | ||
| 125362852 | 12536285 | 7 | 20160622 | 0 |